Back to Search
Start Over
NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
- Source :
- Journal of Clinical Oncology. 36:8537-8537
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- 8537Background: CT-RT is the standard treatment for unresectable LA-NSCLC. P plus vinorelbine is widely used. Metronomic CT is a frequent administration of low doses of CT. mOV has shown good effic...
- Subjects :
- 0301 basic medicine
Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
Chemo-radiotherapy
business.industry
Standard treatment
Low dose
Locally advanced
medicine.disease
Vinorelbine
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Non small cell
Lung cancer
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........93bbaeda419338ed66f0e2a99f52a4c3